TY  - CONF

T1  - Evaluation of the molecular mechanisms for the sequence-dependent, synergistic anti-tumour effects of doxorubicin and zoledronic acid in breast cancer.

JO  - CANCER RESEARCH

PY  - 2009/01/15

AU  - Ottewell PD

AU  - Leftey DV

AU  - Coleman RE

AU  - Holen I

ED  - 

VL  - 69

IS  - 2

SP  - 200S

EP  - 201S

Y2  - 2024/12/21

ER  -